The largest database of trusted experimental protocols

Violet tracer

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Violet Tracer is a laboratory equipment designed for the detection and visualization of specific biomolecules or cellular components. It utilizes a violet-colored fluorescent dye that binds to and labels the target analyte, allowing for its identification and localization within a sample. The core function of the Violet Tracer is to provide a reliable and sensitive method for the analysis and study of biological samples.

Automatically generated - may contain errors

7 protocols using violet tracer

1

Treg Suppression of Thymocyte Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sorted BST2+CD3+ thymocytes, which are enriched in natural Treg, were tested for their suppressive effect on the proliferation of autologous BST2negCD3+ thymocytes labeled with Violet Tracer (Invitrogen) in round bottom 96 well plates (Falcon) coated with T3 antibody (Coulter) at 1.25 μg/ml. Briefly 1×106 sorted BST2negCD3+ thymocytes were stained with 1μl of 5nM Violet Tracer (Invitrogen) at 37°C for 20 min., washed in 5ml of serum free medium, and 50μl at 5×105 cells/ml was added to each well. BST2+CD3+ Treg at 5×105cells/ml were serially 1:2 diluted and 50μl of the diluted cells was added to the Violet Tracer labeled BST2negCD3+ thymocytes. 100μl of serum free medium containing IL-2 (20u/ml), IL-4 (20ng/ml) and anti-CD28 (10ng/ml) was added to a total volume of 200μl/well and the cells were cultured for 5 days at 37°C. at which time the cells were washed and run on an HT LSRII to determine the amount of proliferation of Violet Tracer labeled cells.
+ Open protocol
+ Expand
2

Quantification of CAR T-cell Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
One to three days after transduction, selection and expansion, inducible CD38-CAR T cells were incubated with Luc-GFP-transduced human malignant cell lines or violet tracer (Thermo Fisher) labeled primary BM-MNC for 24 hours. The luciferase signal produced by surviving malignant cell lines was determined after 24 hours with a GloMax® 96 Microplate Luminometer (Promega) within 15 minutes after the addition of 125 μg/mL beetle luciferin (Promega). % lysis cells = (1 − (BLI signal in treated wells / BLI signal in untreated wells)) × 100%. To analyze surviving primary BM-MNCs Flow-Count™ Fluorospheres (Beckman 7547053) were added, cells were harvested and stained for different CD markers (see above). Viable cells were then quantitatively analyzed through Flow-Count-equalized measurements. Percentage cell lysis was calculated as % lysis cells = (1 − (absolute number of viable target cells in treated wells / absolute number of viable target cells in untreated wells)) × 100%.
+ Open protocol
+ Expand
3

Antibody-Mediated Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Violet tracer (Thermo Fisher, Waltham, MA, USA) labeled target cells were pre-incubated with serial dilutions of antibodies for 15 min in 96-well U bottom plates, and then cultured for 24 h without additional effector cells or with effector cells at a fixed (10:1) T-cell to target (E:T) cell ratio. Effector cells were allogeneic or autologous effector PBMCs or, from specified samples, CD3+ lymph node-residing T-cells, isolated using magnetic-activated-cell sorting (MACS) following the manufacturer’s instructions (Miltenyi Biotec, Bergisch Gladbach, Germany). Viable target cells were identified with multicolor flow cytometry. Data were analyzed using FACS DIVA software. Cytotoxicity was calculated only if >500 viable target cells were counted in untreated wells and with the following formula: %Cytotoxicity=(100%viability), %Viability=100*#7AAD_negativeeventsoftestsample#7AAD_negativeeventsofcontrolsample.
Further details are described in online supplementary material and methods.
The concentration of granzyme B released in cell-free supernatants of cytotoxicity assays was measured by a sandwich ELISA kit (Mabtech, Nacka Strand, Sweden) following manufacturer’s protocol.
+ Open protocol
+ Expand
4

Multicolor Flow Cytometry Assay for CAR T-Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry assays were performed on BD LSRFortessa. Viable cells were determined with live/dead cell marker (LIVE/DEAD® Fixable Near-IR; Life Technologies L10119). Transduction efficiency and associated CAR expression was measured with an monoclonal antibody towards NGFR-APC (CD271) (clone ME20.4 Biolegend). Monoclonal antibodies used for cytotoxicity assays: CD3-Fitc (clone SK7), CD14-PerCP (clone MoP9), CD19-PerCP (clone SJ25C1) and CD38-PE (clone HB7) (BD Bioscience). CD56-PC7 (clone N901) and CD138-APC (clone BA38) (Beckman Coulter). To distinguish Mock/CAR T cells from target cells, target cell were stained with 0.5 μM Violet tracer (Thermo Fisher C34571) for 25 minutes and washed before cytotoxicity assay co-cultures. Flow cytometry data analysis was performed with FACS Diva 6.1 software.
+ Open protocol
+ Expand
5

Quantitative Analysis of Cell Lysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Serial dilutions of mock- or CAR-transduced iNKT cells were incubated with target cells for 16–24 h. To distinguish the two cell types, target cells or effector cells were pre-stained with 0.5 µM Violet tracer (Thermo Fisher, Bleiswijk, The Netherlands). After the incubation period, Flow-Count™ Fluorospheres (Beckman Coulter, Woerden, The Netherlands) were added and the cells were harvested and stained for different CD markers (see Section 4.6) to identify different cell subsets. Viable cells were then quantitatively analyzed through Flow-Count-equalized measurements. Percentage cell lysis was calculated as follows and only if the analyzed target cell population contained > 500 viable cells in the untreated samples. % lysis cells = (1 − ((#viable target cells in treated wells/#of beads)/(#viable target cells in untreated wells/#of beads))) × 100%.
+ Open protocol
+ Expand
6

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry assays were performed on BD LSRFortessa. Viable cells were determined with live/dead cell marker (LIVE/DEAD® Fixable Near-IR; Life Technologies L10119). Transduction efficiency and associated CAR expression was measured with an APC conjugated antibody towards NGFR (CD271) (Biolegend) for CAR-4–1BBz-LNGFR and APC antibody 4–1BBL (CD137L) (Biolegend) for CAR-28z-41BBL. CAR-28z-dsRed were measured in the PE-CF594 channel to detect dsRed. Additional antibodies were used for weekly differentation phenotype: CD3, CD4, CD8, CD38, (BD Bioscience), CD45RA and CD62L (Biolegend), for exhaustion assays antibodies: PD-1, LAG-3 and TIM-3 (Biolegend) and for cytotoxicity assays: CD3, CD14, CD19, CD38, CD56 and CD138 (BD Bioscience). To distinguish Mock/CAR T cells from target cells, target cell were stained with 0.5 μM Violet tracer (Thermo Fisher) for 25 minutes and washed before cytotoxicity assay co-cultures. Flow cytometry data analysis was performed with FACS Diva 6.1 software.
+ Open protocol
+ Expand
7

Quantitative CAR T Cell Cytotoxicity Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Seven to ten days after transduction serial dilutions (Effector:Target 3:1, 1:1 or 1:3) of CAR T cells were incubated with Violet tracer (Thermo Fisher) labeled BM-MNC or PBMC for 16–24 hours. After addition of Flow-Count™ Fluorospheres (Beckman 7547053) cells were harvested and stained for different CD markers (see section flow cytometry) to distinguish different subsets. Viable cells were then quantitatively analyzed through Flow-Count-equalized measurements. Percentage cell lysis was calculated as followed and only if the analyzed target cell population contained >500 viable cells in the untreated samples. % lysis cells = 1 − ((# viable target cells in treated wells/# of beads) / (#viable target cells in untreated wells/# of beads)) × 100%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!